Piper Sandler Remains a Hold on Pulmonx (LUNG)
I'm LongbridgeAI, I can summarize articles.Piper Sandler analyst Jason Bednar maintained a Hold rating on Pulmonx (LUNG) with a price target of $2.50. This aligns with the current analyst consensus for the stock.
Piper Sandler analyst Jason Bednar maintained a Hold rating on Pulmonx today and set a price target of $2.50.
Claim 55% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
Bednar covers the Healthcare sector, focusing on stocks such as Align Tech, Henry Schein, and Merit Medical Systems. According to TipRanks, Bednar has an average return of -3.3% and a 43.90% success rate on recommended stocks.
Currently, the analyst consensus on Pulmonx is a Hold with an average price target of $2.50.